Literature DB >> 19803377

Why does tuberculosis lead to specific inflammation?

Isamu Sugawara1.   

Abstract

When Mycobacterium tuberculosis infects humans, about 20% of those infected actually develop tuberculosis (TB). In Japan, the incidence of TB in 2008 was 24,760 cases (19.4/100,000 persons) and the rate has been decreasing gradually, but is still higher than in the USA, Holland, and Belgium, for example. Histologically, tuberculosis displays exudative inflammation, proliferative inflammation and productive inflammation depending on the time course. In productive inflammation, granulomatous lesions with necrotic centers are formed. The typical granulomas consist of epithelioid macrophages, Langhans' multinucleated giant cells, lymphocytes and fibroblasts, and the process of their formation involves many cytokines, chemokines and transcription factors. These findings have been derived primarily from animal experiments utilizing an airborne infection apparatus. The conditions for airborne infection have been described in detail elsewhere. This mini-review focuses on what has been found through animal experiments, and also indicates areas for which data are not currently available.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19803377     DOI: 10.5025/hansen.78.263

Source DB:  PubMed          Journal:  Nihon Hansenbyo Gakkai Zasshi        ISSN: 1342-3681


  4 in total

1.  Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection.

Authors:  Valerie R Stolberg; Bo-chin Chiu; Brian E Martin; Samir A Shah; Matyas Sandor; Stephen W Chensue
Journal:  J Innate Immun       Date:  2010-10-29       Impact factor: 7.349

2.  CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during Mycobacterium bovis infection.

Authors:  Valerie R Stolberg; Bo-Chin Chiu; Brian M Schmidt; Steven L Kunkel; Matyas Sandor; Stephen W Chensue
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

3.  Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model.

Authors:  Selvakumar Subbian; Liana Tsenova; Jennifer Holloway; Blas Peixoto; Paul O'Brien; Véronique Dartois; Vikram Khetani; Jerome B Zeldis; Gilla Kaplan
Journal:  EBioMedicine       Date:  2016-01-14       Impact factor: 8.143

4.  Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia.

Authors:  Emad Ali Al Khoufi
Journal:  Pan Afr Med J       Date:  2021-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.